01 1AX Pharmaceutical Corp
02 1DARMERICA, LLC
03 1Fagron Inc
04 1Fagron Services B.V.
05 1Gabar Health Sciences Corp.
06 1Inga Pharmaceuticals
07 1LETCO MEDICAL, LLC
08 1Medisca Inc.
09 1PROFESSIONAL COMPOUNDING CENTERS OF AMERICA
10 1Pharma Source Direct, Inc.
11 1Professional Compounding Centers of America
12 1Professional Compounding Centers of America dba PCCA
13 1RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA
14 1Saurav Chemicals Limited
15 1SpecGx LLC
16 2Willow Birch Pharma, Inc.
01 11 X Papaverine Wet
02 4PAPAVERINE HYDROCHLORIDE
03 3Papaverine HCL
04 4Papaverine HCl
05 5Papaverine Hydrochloride
01 1Canada
02 2India
03 1Ireland
04 1Italy
05 2Netherlands
06 6U.S.A
07 3United Kingdom
08 1Blank
NDC Package Code : 51552-0416
Start Marketing Date : 2004-09-01
End Marketing Date : 2027-09-02
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 0406-7831
Start Marketing Date : 2010-12-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-0454
Start Marketing Date : 2014-07-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-0223
Start Marketing Date : 2022-01-04
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-0315
Start Marketing Date : 2023-08-30
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-1775
Start Marketing Date : 2013-06-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 12711-7480
Start Marketing Date : 2001-06-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 43235-0009
Start Marketing Date : 2018-09-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 10695-116
Start Marketing Date : 2023-07-10
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 10695-116
Start Marketing Date : 2023-06-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
A Papaverine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Papaverine Hydrochloride, including repackagers and relabelers. The FDA regulates Papaverine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Papaverine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Papaverine Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Papaverine Hydrochloride supplier is an individual or a company that provides Papaverine Hydrochloride active pharmaceutical ingredient (API) or Papaverine Hydrochloride finished formulations upon request. The Papaverine Hydrochloride suppliers may include Papaverine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Papaverine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Papaverine Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Papaverine Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Papaverine Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Papaverine Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Papaverine Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Papaverine Hydrochloride suppliers with NDC on PharmaCompass.
We have 12 companies offering Papaverine Hydrochloride
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
